Teladoc Health (NYSE: TDOC) shares have crumbled 65% in the past year as compared to the S&P 500, which has returned 7% over the same time frame. The company's decline in value is part of a broader tech sell-off related to rising interest rates, inflation, and fear surrounding the war in Ukraine.
Why is Teladoc Health stock down 65% in the last year?
Jan 10, 2022 · Why Shares of Teladoc Sank in 2021 By Jason Hawthorne - Jan 9, 2022 at 9:58PM Key Points Shares were decimated in 2021 as membership growth slowed. The stock now trades at multiples it hasn't seen...
Why is Teladoc’s sales growth slowing?
Oct 05, 2021 · Shares of online healthcare company Teladoc ( TDOC -5.25% ) dropped 12.2% in September according to data provided by S&P Global Market Intelligence. The stock opened at $144.86 per share on Sept ...
Is it time to follow the crowd’s changing diagnosis on Teladoc (TDOC)?
Jul 07, 2021 · Why Teladoc Stock Is Falling Today Investors may be reading too much into declining COVID numbers in the U.S. What happened Shares of Teladoc Health ( TDOC -9.35% ) were falling 3% as of 11:45 a.m....
What do analysts expect from Teladoc stock in 2022?
9 hours ago · Teladoc Health (NYSE: TDOC) shares have crumbled 65% in the past year as compared to the S&P 500, which has returned 7% over the same time frame. The company's decline in value is part of a broader...
Is Teladoc a good stock to buy?
2. It's projecting good growth through at least 2024. Over the next few years, Teladoc probably won't wow investors as it did with its wild run-up in 2020 and 2021, but it's planning to deliver faster-than-average growth nonetheless, and that's another reason its shares could be worth picking up.Mar 5, 2022
Will Teladoc stock recover?
Teladoc stock is set for a big comeback, says Goldman Sachs. Teladoc (ticker: TDOC) stock was battered in 2021. Though memberships boomed as the pandemic unfolded in 2020, sending the stock up nearly 139% that year, such gains created a high bar that Teladoc struggled to clear the following year.Feb 11, 2022
Why is Teladoc stock so low?
Teladoc stock has fallen in large part because of valuation concerns. The virtual-care market opportunity, though, is huge. Teladoc is well positioned to dominate in this market over the long term.Jan 2, 2022
Is there a future for Teladoc?
Teladoc is expected to report a net loss of $3.18/share in 2021, resulting in 41% growth from -$5.36/share in the fiscal year 2020. The consensus EPS estimate for the fiscal year 2025 is $2.57/share, or 181% growth from 2021 expectations.Jan 25, 2022
Will teladoc ever be profitable?
Teladoc has never turned a profit -- at least not using generally accepted accounting principles (GAAP). Yet hypergrowth fueled by the pandemic and a few acquisitions have pushed revenue up nearly three-fold since the end of 2019.Mar 1, 2022
What's happening to teladoc?
Teladoc's market capitalization was cut in half through 2021 and is down to $13.2 billion. That's a 70% collapse from its peak in February. Further, the company's value as a multiple of gross profit is at a multiyear low; the ratio bottomed at 12 during pullbacks in 2018 and 2019.Jan 9, 2022
Is teladoc overvalued?
Given these points, I continue to recommend selling TDOC stock. Although the company does have some positive catalysts, including its partnership with CVS (NYSE:CVS) and its strong brand name, the shares remain tremendously overvalued, despite their recent pullback.Dec 1, 2021
Is teladoc a long term buy?
The performance in Teladoc Health (NYSE:TDOC) stock has been unimpressive over the past year. After a euphoric listing, investor's focus has shifted to the company's ability to deliver high-growth and robust cash flows.Jan 31, 2022